Team:Heidelberg/Team Members

From 2009.igem.org

(Difference between revisions)
Line 7: Line 7:
  h2 {padding: 10px 20px;
  h2 {padding: 10px 20px;
                         font-size: 18px;
                         font-size: 18px;
-
                         color: eb8300;}
+
                         color: eb8300;
 +
                        font-decoration: none;
 +
                        font-weight: bold;}
.gallery{ width: 640px;
.gallery{ width: 640px;
Line 153: Line 155:
<img src="https://static.igem.org/mediawiki/2009/0/02/HD09_Roland_Eils_picture.png" alt="" width="120px"/>
<img src="https://static.igem.org/mediawiki/2009/0/02/HD09_Roland_Eils_picture.png" alt="" width="120px"/>
<p>Prof. Eils is again the head of the iGEM Heidelberg team. He provides the laboratories and all the required equipment. Besides, he will sponsor the traveling and participation costs. Thank you very much!
<p>Prof. Eils is again the head of the iGEM Heidelberg team. He provides the laboratories and all the required equipment. Besides, he will sponsor the traveling and participation costs. Thank you very much!
-
The research interests of Prof. Eils lies in the field of the analysis and mathematical modeling of complex pathways in molecular biology. He can look back at a very successful career, as he is the head of the Department of Theoretical Bioinformatics in the DKFZ and working on computational oncology. Furthermore, he is the director of the Department of Bioinformatics and Functional Genomics of the IPMB at the University of Heidelberg. Alongside Prof. Kräusslich and Prof. Wolfrum, he is one of three founding directors of the BioQuant, as well as the leader of the Systems Biology Center and the representative of the FORSYS-Initiative of Heidelberg’s research network, the ViroQuant. He has won numerous awards; in particular he has been awarded the Biofuture price (approx. 1.2 Million €) by the BMBF for innovations allowing the graphical reconstruction of the eukaryotic mitosis process from 4D microscopy images and in the year 2005 he won the award for new innovative research by Helmholtz Society: “SystemsBiology of Complex Diseases”. Besides, he was one of the main organizers of the International Conference on Systems Biology in Heidelberg 2004 and he organized the German Symposium on Systems Biology 2009. His new engagement in the up-coming field of Synthetic Biology underlines the need for tight interdisciplinary work between experimentalists and theoreticians.</p>
+
The research interests of Prof. Eils lies in the field of the analysis and mathematical modeling of complex pathways in molecular biology. He can look back at a very successful career, as he is the head of the Department of Theoretical Bioinformatics in the DKFZ and working on computational oncology. Furthermore, he is the director of the Department of Bioinformatics and Functional Genomics of the IPMB at the University of Heidelberg.</p>
</div>
</div>
 +
 +
<div class="adv_gallery"><p>
 +
Alongside Prof. Kräusslich and Prof. Wolfrum, he is one of three founding directors of the BioQuant, as well as the leader of the Systems Biology Center and the representative of the FORSYS-Initiative of Heidelberg’s research network, the ViroQuant. He has won numerous awards; in particular he has been awarded the Biofuture price (approx. 1.2 Million €) by the BMBF for innovations allowing the graphical reconstruction of the eukaryotic mitosis process from 4D microscopy images and in the year 2005 he won the award for new innovative research by Helmholtz Society: “SystemsBiology of Complex Diseases”. Besides, he was one of the main organizers of the International Conference on Systems Biology in Heidelberg 2004 and he organized the German Symposium on Systems Biology 2009. His new engagement in the up-coming field of Synthetic Biology underlines the need for tight interdisciplinary work between experimentalists and theoreticians.</p></div>
 +
<div class="clear"></div>
<div class="adv_gallery"> <h3> Tobias Bauer</h3>
<div class="adv_gallery"> <h3> Tobias Bauer</h3>
Line 160: Line 166:
<p>Tobias is a PhD student at Prof. Roland Eils' workgroup at the University of Heidelberg and the German Cancer Research Center (DKFZ). He's part of the network modeling subgroup lead by Dr. Rainer König within which his focus is on gene regulatory networks. Although he exclusively works in bioinformatics, he studied Biology at Mainz University majoring in molecular genetics. Tobias' main interest today is how gene regulation "programs" are composed and how they interact on a genome-wide basis, especially in cancer and disease. His support of the team is mostly computationally, and he's looking forward to contributing his experience gained on his PhD-project to this year's iGEM Team Heidelberg.</p>
<p>Tobias is a PhD student at Prof. Roland Eils' workgroup at the University of Heidelberg and the German Cancer Research Center (DKFZ). He's part of the network modeling subgroup lead by Dr. Rainer König within which his focus is on gene regulatory networks. Although he exclusively works in bioinformatics, he studied Biology at Mainz University majoring in molecular genetics. Tobias' main interest today is how gene regulation "programs" are composed and how they interact on a genome-wide basis, especially in cancer and disease. His support of the team is mostly computationally, and he's looking forward to contributing his experience gained on his PhD-project to this year's iGEM Team Heidelberg.</p>
</div>
</div>
-
<div class="clear"></div>
 
<div class="adv_gallery"> <h3> Martí Bernardo Faura</h3>
<div class="adv_gallery"> <h3> Martí Bernardo Faura</h3>
Line 166: Line 171:
<p>Martí was born in Barcelona, where he finished his Bachelor of Science in Computer Science Engineering and his Master of Science in Pharmaceutical Industry and Biotechnology. Currently, he is a Ph.D student in the group of Theoretical Bioinformatics and the Institut für Pharmazie und Molekulare Biotechnologie at the Universität Heidelberg. In his Ph.D. thesis, Martí is focusing on data-driven modeling to elucidate the relationship between apoptosis and autophagy in terms of nonlinear interactions and enjoys working in the intersection of theoretical and experimental biology. He is surprised to be writing about himself in the third person. He is very happy to join this project and will support the modeling team and help with the in silico simulations.</p>
<p>Martí was born in Barcelona, where he finished his Bachelor of Science in Computer Science Engineering and his Master of Science in Pharmaceutical Industry and Biotechnology. Currently, he is a Ph.D student in the group of Theoretical Bioinformatics and the Institut für Pharmazie und Molekulare Biotechnologie at the Universität Heidelberg. In his Ph.D. thesis, Martí is focusing on data-driven modeling to elucidate the relationship between apoptosis and autophagy in terms of nonlinear interactions and enjoys working in the intersection of theoretical and experimental biology. He is surprised to be writing about himself in the third person. He is very happy to join this project and will support the modeling team and help with the in silico simulations.</p>
</div>
</div>
 +
<div class="clear"></div>
<div class="adv_gallery"> <h3> Phillip Hundeshagen</h3>
<div class="adv_gallery"> <h3> Phillip Hundeshagen</h3>
Line 171: Line 177:
<p>Phillip is currently a Ph.D. student in the Applied Systems Biology Group of Professor Eils at Bioquant and DKFZ. During his Ph.D. thesis he is working on the crosstalk between apoptosis and autophagy. He is mainly interested in the development and application of novel high-throughput/high-content approaches to study cellular decisions on a comprehensive level. He joined the iGEM –team as an advisor/mentor and is very happy to contribute to this exciting and promising project.</p>
<p>Phillip is currently a Ph.D. student in the Applied Systems Biology Group of Professor Eils at Bioquant and DKFZ. During his Ph.D. thesis he is working on the crosstalk between apoptosis and autophagy. He is mainly interested in the development and application of novel high-throughput/high-content approaches to study cellular decisions on a comprehensive level. He joined the iGEM –team as an advisor/mentor and is very happy to contribute to this exciting and promising project.</p>
</div>
</div>
-
<div class="clear"></div>
+
 
<div class="adv_gallery"> <h3> Jens Keienburg</h3>
<div class="adv_gallery"> <h3> Jens Keienburg</h3>
Line 177: Line 183:
<p>Jens is a PhD student in the bioinformatics group of Professor Eils at Bioquant. He has studied Molecular Biotechnology and is very glad to support now for the second time such a versatile team of avant-garde students.</p>
<p>Jens is a PhD student in the bioinformatics group of Professor Eils at Bioquant. He has studied Molecular Biotechnology and is very glad to support now for the second time such a versatile team of avant-garde students.</p>
</div>
</div>
 +
<div class="clear"></div>
<div class="adv_gallery"> <h3> Anna-Lena Kranz</h3>
<div class="adv_gallery"> <h3> Anna-Lena Kranz</h3>
Line 182: Line 189:
<p>Anna-Lena is a PhD student in the group of Roland Eils at the Institute for Pharmacy and Molecular Biotechnology at the University of Heidelberg and the DKFZ. She studied Bioinformatics and Genome Research at the University of Bielefeld and acquired her Master’s degree in Information Technology at Macquarie University in Sydney, Australia. In her PhD, Anna is interested in analyzing gene expression data on metabolic networks and has recently focused on transcriptional regulation. She is excited to support the Heidelberg team and contributes mainly to the computational work of the iGEM team.</p>
<p>Anna-Lena is a PhD student in the group of Roland Eils at the Institute for Pharmacy and Molecular Biotechnology at the University of Heidelberg and the DKFZ. She studied Bioinformatics and Genome Research at the University of Bielefeld and acquired her Master’s degree in Information Technology at Macquarie University in Sydney, Australia. In her PhD, Anna is interested in analyzing gene expression data on metabolic networks and has recently focused on transcriptional regulation. She is excited to support the Heidelberg team and contributes mainly to the computational work of the iGEM team.</p>
</div>
</div>
-
<div class="clear"></div>
+
 
<div class="adv_gallery"> <h3>Michaela Reichenzeller</h3>
<div class="adv_gallery"> <h3>Michaela Reichenzeller</h3>
Line 188: Line 195:
<p>Michaela did her PhD on the structure and dynamics of the interchromosomal domain compartment in eukaryotic cells in the department for Cell Biology at the German Cancer Research Center, DKFZ in Heidelberg. Following her PhD she worked as a Postdoc in the lab of Prof. Dr. Harald Herrmann on nuclear intermediate filament proteins called lamins. She investigated the influence of disease-related mutations in A- and B-type lamins on nuclear morphology. In 2005 she joined the group of Prof. Roland Eils. The main focus of her work is now on DNA double strand break repair by non-homologous end-joining (NHEJ) and homologous recombination (HR). She is investigating protein-protein interactions in living cells by using FRAP technology and kinetic modeling. The longterm goal of her project is to understand mechanisms of pathway choice between NHEJ and HR. She likes to support the students team with all her expertise in current molecular and cell biological as well as imaging techniques.</p>
<p>Michaela did her PhD on the structure and dynamics of the interchromosomal domain compartment in eukaryotic cells in the department for Cell Biology at the German Cancer Research Center, DKFZ in Heidelberg. Following her PhD she worked as a Postdoc in the lab of Prof. Dr. Harald Herrmann on nuclear intermediate filament proteins called lamins. She investigated the influence of disease-related mutations in A- and B-type lamins on nuclear morphology. In 2005 she joined the group of Prof. Roland Eils. The main focus of her work is now on DNA double strand break repair by non-homologous end-joining (NHEJ) and homologous recombination (HR). She is investigating protein-protein interactions in living cells by using FRAP technology and kinetic modeling. The longterm goal of her project is to understand mechanisms of pathway choice between NHEJ and HR. She likes to support the students team with all her expertise in current molecular and cell biological as well as imaging techniques.</p>
</div>
</div>
 +
<div class="clear"></div>
<div class="adv_gallery"> <h3> Yara Reis</h3>
<div class="adv_gallery"> <h3> Yara Reis</h3>
Line 193: Line 201:
<p>Yara comes from Portugal where she studied Biochemistry. During her Master thesis in Lisbon, she got the opportunity to visit Heidelberg and decided to stay for her PhD. She is at Prof. Eils research group working on Systems Biology applied to Programmed Cell death in cancer cells. She will support the Heidelberg team in the experimental work and with good mood!</p>
<p>Yara comes from Portugal where she studied Biochemistry. During her Master thesis in Lisbon, she got the opportunity to visit Heidelberg and decided to stay for her PhD. She is at Prof. Eils research group working on Systems Biology applied to Programmed Cell death in cancer cells. She will support the Heidelberg team in the experimental work and with good mood!</p>
</div>
</div>
-
<div class="clear"></div>
+
 
<div class="adv_gallery"> <h3> Daniela Richter</h3>
<div class="adv_gallery"> <h3> Daniela Richter</h3>

Revision as of 10:55, 10 October 2009

Students

Advisors

Lorem ipsum dolor sit amet